Arch Virol 2006, 151:113–125 CrossRefPubMed 47 Cisneros-Solano A

Arch Virol 2006, 151:113–125.CrossRefPubMed 47. Cisneros-Solano A, Moreno-Altamirano MM, Martínez-Soriano U, Jimenez-Rojas F, Díaz-Badillo A, Muñoz ML: Sero-epidemiological and virological investigation R788 mouse of dengue infection in Oaxaca, Mexico, during 2000–2001. Dengue Bulletin 2004, 28:28–34. 48. Sambrook J, Fritsch EF, Maniatis T: Strategies for cloning in plasmid vectors. Molecular cloning: A laboratory manual 2 Edition

(Edited by: Nolan C). New York. Cold Spring Harbor Laboratory Press 1989, 1:1.53–1.72. 49. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nu Acids Resear 1994, 22:4673–4680.CrossRef 50. Martin DP, Williamson C, Posada D: RDP2: recombination detection and analysis from sequence alignments. Bioinformatics 2005, 21:260–262.CrossRefPubMed 51. Jin L, Nei M: Limitations of the evolutionary parsimony method of phylogenetic analysis. Mol Biol Evol 1990, 7:82–102.PubMed 52. Sugiura N: Further analysis of the data by Akaike’s information criterion and the finite corrections. Comm Statist 1978, 7:13–26.CrossRef Authors’ contributions GPR obtained the isolates and clones, carried out the RT-PCR assays using

RNA from passages 3 to sequence the partial C91-prM-E-NS12400 genome and E gene to develop recombination and phylogenetic analysis. ADB determined serotype and helped in the phylogenetic analysis. MCN participated in obtaining the clones of E gene. AC, collected serum samples from patients from Oaxaca and helped to obtain the isolates and Metformin mouse clinical data from Oaxaca, Mexico. GPR and MLM participated in the writing and discussion of results, helped to review the manuscript and assisted with the literature validation. MLM proof-read and assembled the manuscript. All authors participated in the discussion of results and read and approved the final manuscript.”
“Background Pseudomonas syringae is an important Gram-negative bacterium that infects

a wide variety of plant species and causes disease symptoms ranging Florfenicol from leaf spots to stem cankers in agriculturally important crops. Bacteria such as P. syringae often live as epiphytes on the leaf surface without causing any obvious disease symptoms. However, under permissible conditions of temperature and humidity, P. syringae can enter the plant through natural openings such a stomata and hydathodes or via mechanical wounds [1–3]. Once bacteria enter the intercellular spaces (the apoplast), they can withstand preformed defense molecules, obtain nutrients and multiply to cause damage to the host tissue [1]. The identities of the pathogenic factors involved in these processes are largely unknown, and how they function to promote parasitism and disease is also poorly understood [4]. Adaptation of P.

The SEM cross-section images as shown in Figure 3c,d are prepared

The SEM cross-section images as shown in Figure 3c,d are prepared by cleaving the silicon sample. The cleaving causes rough edges, and the brittle nature of the thin film results in numerous regions without material. However, the presence of the thin buffer layer is evident, and the thickness matches with the data from ellipsometry measurements. The grain sizes of the films deposited at 700°C with a buffer layer of thickness of 7.2 nm are found to be between 30 and 50 nm, which PLX3397 is comparable to the other reported

values [21]. AFM measurements are carried out to estimate the roughness properties of the BTO films. The AFM images of the 150-nm-thick BTO films deposited at 700°C for different thicknesses of the buffer layers are shown in Figure 4a,b. The film deposited with the 4.4-nm buffer layer shows a roughness less than 10 nm, whereas the films deposited with buffer layers greater than 6 nm, show a larger roughness (10 to 15 nm) because of larger grain sizes. Figure 4 AFM images of BTO thin films deposited at 700°C for different thicknesses of intermediate buffer layers. (a) 6 nm and (b) 7.2 nm. Dielectric and ferroelectric properties The dielectric and ferroelectric properties of BTO thin

films (thickness 150 nm, this website annealing temperature 700°C) grown on lanthanum oxynitrate buffer layers (thickness 7.2 nm or 8.9 nm, heat treatment 450°C) are estimated with C-V and P-E measurements. The C-V measurement shows the small signal capacitance as a function of a bias DC voltage (see Figure 5a). The butterfly shape indicates the ferroelectric hysteresis nature of the BTO tetragonal films. Two maxima for the dielectric constants are observed depending on an increase or decrease in the bias electric field. Figure 5 AC dielectric constant and P – E hysteresis loop. (a) AC dielectric constant as a function of the DC bias voltage for a BTO thin film (150 nm)

annealed at 700°C with a 7.2-nm-thick buffer layer. (b) P-E hysteresis loop measured at 1 KHz with an AC voltage swing of 10 V-PP for the BTO films annealed at 700°C with buffer layers of different thickness. The samples O-methylated flavonoid deposited with buffer layers below 6 nm often show electrical short circuit between the top and bottom contacts due to the intercrystal void formation. However, the highly oriented BTO films (150 nm) deposited on a BTO seed layer with buffer layers thicker than 7 nm, followed by layer-by-layer coating and annealing procedure (30 nm each time), show well-defined hysteresis loops. The BTO thin films (150 nm) appear to be stable, without breakdown up to electric fields of 400 kV/cm. The polarization of the films does not reach saturation due to the electrical breakdown at higher voltages. The films deposited with a 7-nm buffer layer show a dielectric constant of 270, remnant polarization of (2P r) 3 μC/cm2, and coercive field (E c) of 60 kV/cm, whereas the BTO film deposited on an 8.9-nm buffer layer shows a 2P r of 5 μC/cm2 and E c of 100 kV/cm.

MIC values correspond to the concentration of P-PRP present in th

MIC values correspond to the concentration of P-PRP present in the last well in which a bacterial growth is observable. The assay was performed in duplicate for each strain and, if the two MIC differed by more than two wells, the assay was repeated. Results were expressed as mean ± standard deviation. A minimum bactericidal concentration (MBC) test click here was also performed. MBC is the lowest concentration of a substance required to kill a particular

bacterium. It was determined from broth microdilution MIC tests by subculturing 100 μl of bacterial suspension to agar media. Results As expected, the P-PRP produced was leukocyte-depleted (0,34 ± 0,27) × 103/μl. In order to obtain the minimum platelet concentration ranges of P-PRP capable of inhibiting bacterial growth, we calculated the mean MIC of the 5 strains tested for each microorganism.

Values are presented in Table 1. MIC are expressed as number of platelets/μl. As can be seen from the data, the Dabrafenib ic50 platelet concentration ranges are fairly uniform among microorganisms, except for C. albicans, whose range of MIC is about twice the others, and for P. aeruginosa, which is not inhibited by P-PRP. S. oralis seems to be more sensible than other bacteria to the antibacterial activity of P-PRP. No differences were observed between E. oralis 1 34.475 ± 13.488 29.550 ± 11.013 88.650 ± 22.025 34.457 ± 13.504 8.618 ± 3.372 2 32.500 ± 19.902 35.750 ± 17.801 117.000 ± 29.069 39.000 ± 14.534

3.250 ± 1.112 3 5.738 ± 2.138 4.303 ± 1.069 61.200 ± 20.950 26.775 ± 10.475 3.346 ± 1.310 4 12.488 ± 3.103 16.650 ± 6.205 49.950 ± 12.410 8.305 ± 3.114 7.650 ± 2.619 5 7.613 ± 5.004 6.831 ± 5.263 112.500 ± 27.951 10.937 ± 4.279 2.734 ± 1.070 6 13.956 ± 6.949 13.956 ± 6.949 81.200 ± 27.797 8.881 ± 3.475 7.612 ± 2.837 7 6.581 ± 1.635 5.850 ± 2.006 210.600 ± 52.324 17.550 ± 6.540 26.325 ± 6.540 8 5.375 ± 3.292 5.913 ± 2.944 68.800 ± 23.552 34.400 ± 11.776 34.400 ± 11.776 9 28.425 ± 10.593 21.319 ± 5.297 75.800 ± 25.948 Glycogen branching enzyme 8.290 ± 3.243 8.290 ± 3.244 10 5.611 ± 2.195 4.809 ± 1.792 38.475 ± 14.339 12.825 ± 4.391 14.428 ± 3.585 11 24.200 ± 8.284 21.175 ± 8.284 108.900 ± 27.056 36.300 ± 13.528 33.275 ± 16.569 12 14.000 ± 4.793 13.125 ± 6.187 31.500 ± 7.826 15.750 ± 3.913 17.500 ± 10.717 13 9.075 ± 4.519 10.725 ± 5.534 39.600 ± 14.758 33.000 ± 20.208 29.700 ± 7.279 14 19.906 ± 11.682 15.641 ± 11.682 68.250 ± 25.435 15.640 ± 7.788 4.976 ± 1.947 15 24.850 ± 9.722 21.300 ± 7.938 63.900 ± 15.876 49.700 ± 19.444 6.212 ± 2.431 16 14.850 ± 10.757 11.550 ± 4.519 46.200 ± 18.075 9.

Patient characteristics from which tumor and normal samples were

Patient characteristics from which tumor and normal samples were obtained are described Selleck R788 in Table 1. IHC staining for Trop-2 were performed on 4-μm-thick sections of formalin-fixed, paraffin-embedded tissue with purified goat polyclonal antibody against the recombinant human Trop-2 extracellular domain (R&D Systems, Inc., Minneapolis, MN; diluted 1:100), as described previously [9]. Table 1 Patient Characteristics Pathology and Tissue Type (number) Age in Years Race Stage   Mean (SD) AA 1 C 2 I II III IV Formalin Fixed NEC3(5) 66 (4) 3 2         Formalin Fixed NOVA4 (3) 67 (6) 1 2         Formalin Fixed UMMT and OMMT                 UMMT (26) 66 (9) 10 16

14 4 5 3 OMMT (14) 72 (7) 5 9 4 3 5 2 Carcinosarcoma cell lines                 Primary UMMT (2) 58 (12) 1 1 1 1     Primary OMMT (2) 67 (9) 1 1   1   1

1AA – African-American 2 C – Caucasian 3NEC – Normal Endometrial Cells 4NOVA – Normal Ovarian Cells Establishment of Carcinosarcoma Cell Lines Study approval was obtained from the Institutional Review Board and informed consent was obtained from all patients, per institutional guidelines. Fresh, surgical tumor biopsies were collected and patients were staged according to the International Federation of Gynecologists and Obstetricians 1988 operative staging system. Two primary uterine carcinosarcoma cell lines (UMMT-ARK-1 and UMMT-ARK-2) and two primary ovarian carcinosarcoma cell lines (OMMT-ARK-1 and OMMT-ARK-2) were established after sterile processing of surgical specimens as Metformin clinical trial previously described [9, 10]. Briefly, tumor tissue was mechanically minced to portions no larger than 1 to 3 mm3 in an enzyme solution made of 0.14% collagenase type I (Sigma) and 0.01% DNase (Sigma, 2000 KU/mg) in RPMI 1640, and incubated in the

same solution in a magnetic stirring apparatus for an hour at room temperature. Enzymatically dissociated cells were then washed Florfenicol twice in RPMI 1640 with 10% fetal bovine serum and maintained in RPMI supplemented with 10% fetal bovine serum, 200 μg/ml of penicillin and 200 μg/ml of streptomycin at 37°C, 5% CO2 in 75 cm2 tissue culture flasks or Petri dishes (Corning). After seeding on plasticware for 48-72 hours, nonadherent cells and contaminant inflammatory cells were gently removed from the culture by multiple washings with PBS. Both UMMTs were homologous and established from uterine biopsies of chemotherapy naïve patients at the time of staging surgery. UMMT-ARK-1 and UMMT-ARK-2 were established from patients harboring FIGO stage I and FIGO stage II disease, respectively. Of the OMMTs, one was homologous and one heterologous; both were obtained from metastatic sites in patients harboring recurrent, chemotherapy-resistant disease. These patients were initially diagnosed with FIGO stage II (OMMT-ARK-2) and FIGO stage IV (OMMT-ARK-1) ovarian cancer.

The majority of these patients, regardless of the initial diagnos

The majority of these patients, regardless of the initial diagnosis, considered the examination of the utmost importance and were determined to undergo it even if their personal approach to the test was characterized by different moods; only 3% of patients considered follow-up imaging no longer useful and reported their unwillingness to undergo clinical check-ups because of a deep state of anxiety. Although there are no studies in this direction, the damage caused to patients as a result of unnecessary testing should be emphasized; harm related to the loss of working days, transfer expenses, and especially stress related to the expectation and execution buy Belinostat of the examination. The same stress may also be the indirect

LDE225 in vitro cause of the high value assigned by our oncological patients to the examination itself, thus triggering dangerous feedback. In our opinion this problem could be significantly reduced by creating new referral pathology centers where physicians are able to carry out correct work-up of the patients, share

clinical data and establish complete computerized centralization of requests with an updated list of all the diagnostic, as well as therapeutic procedures performed, along with their final outcome also in order to reduce unnecessary/harmful repetition of the same diagnostic tests. Furthermore, we hope for strict compliance with existing guidelines, or the creation of new, universally accepted guidelines that provide better clinical and legal justification of the timing and nature of diagnostic tests required for the follow-up of melanoma, and consequently reduce the problem of defensive medicine emerging in Italy’s medical-legal framework. Conclusion To conclude, it Phosphoribosylglycinamide formyltransferase is clear that about 30% of the US diagnostic examinations performed are unjustified according to the general guidelines currently in use. Therefore, they have not been requested according to strict clinical scientific parameters, but for other reasons, possibly medical-legal ones. Thus, there is need for

the adoption of new shared, widely accepted and easily applicable guidelines, also in light of other considerations related to health costs and medical-legal aspects. Given that said issues represent a thorny issue for other referral centers, we consider it absolutely necessary to update existing guidelines to make for easier use by specialists as well as General Practitioners. Electronic supplementary material Additional file 1: Form. (DOC 124 KB) References 1. Reed KB, Brewer JD, Lohse CM, Bringe K, Pruitt CN, Gibson LE: Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. Mayo Clin Proc 2012,87(4):328–334.PubMedCrossRef 2. Cristofaro M, Busi Rizzi E, Schininà V, Chiappetta D, Angeletti C, Bibbolino C: Appropriateness: analysis of outpatient radiology requests. Radiol med 2012, 117:322–332.PubMedCrossRef 3. De Filippo M, Corsi A, Evaristi L, et al.

Results from the current study suggest that CMR was

unabl

Results from the current study suggest that CMR was

unable to improve perceptions of pleasure and activation. In contrast, Rollo et al. [7] reported that CMR increased feelings of pleasure during the first five minutes of a 30 min running procedure. Discrepancies between these findings are likely to be due to the different demands of the exercise RXDX-106 nmr protocols. Specifically, the aim of Rollo and colleagues protocol was to sustain a pace, which denoted a rating of 15 on the RPE scale [7], while the current study required participants to perform the sprints of the LIST and RSA tests. Perhaps, as optimal performance in the current study required participants to perform maximally during the sprints, the overriding motivation to perform well may have negated any small changes in the feelings of pleasure-displeasure and activation induced by the presence of CHO in the oral cavity Fluorouracil in vivo [30]. In addition, any central changes caused by CMR may be evident for multiple sprint activity

of 60 min or greater in duration. Though further research is required to confirm this notion, it may be supported by Backhouse et al. [18] who reported that CHO ingestion only improves perceived activation between 60 and 90 min of the LIST protocol. Hypothetically, Carter et al. [5] suggest that CMR results in a cephalic rise in insulin and blood glucose, which improves performance by facilitating glucose uptake into the muscle. Contrary to this postulation, our current study indicates that CMR exerts no effect on blood glucose during multiple sprint exercise. This agrees with previous literature reporting that CMR has no influence on blood glucose concentrations during endurance exercise [31]. Although we did not measure peripheral changes in metabolism in our current study, our results support to the notion that CMR exerts little or no metabolic changes.

Despite the ALOX15 relatively small sample size of our study, we are confident in our findings. A major strength of our current study is that it represents a fairly “real world” testing scenario synonymous with sport as the LIST correlates well with soccer and hockey performance [16, 32]. Overall, we used a randomized, crossover treatment assignment to CMR and placebo conditions, whereby participants in our study served as their own controls. The results of our RSA test coefficient of variations for fastest and mean sprint time (1.2%) were similar to other studies using RSA tests [33] and LIST [16]. The trivial effect sizes between trials questions whether there is any ergogenic influence of CMR on multiple sprint performance. We also observed very low coefficients of variation between testing each testing condition (all, < 2.0%). Thus, our study was additionally robust owing to the small variance that we observed between testing conditions, which ultimately attest to the reliability of our study protocol.

Appl Phys Lett 2000, 77:663–665 CrossRef 47 Hong BH, Lee JY, Bee

Appl Phys Lett 2000, 77:663–665.CrossRef 47. Hong BH, Lee JY, Beetz T, Zhu Y, Kim P, Kim KS: Quasi-continuous growth of ultralong carbon nanotube arrays. J Am Chem Soc 2005, 127:15336–15337.CrossRef 48. Chen C-Y, Huang J-H, Lai K-Y, Jen Y-J, Liu C-P, He J-H: Giant optical anisotropy of oblique-aligned ZnO nanowire arrays. Opt Express 2012, 20:2015–2024.CrossRef PF-02341066 concentration Competing interests The authors declare that they have no competing interests. Authors’ contributions JC analyzed the experimental data and drafted the manuscript. KK carried out the experiments. JK

initiated and supervised the work. All authors read and approved the final manuscript.”
“Background The self-assembly of small functional molecules into supramolecular structures is a powerful approach toward the development of new nanoscale materials and devices [1–7]. As a novel class of self-assembled materials, low weight molecular organic gelator (LMOG) gels organized in

regular nanoarchitectures through specific noncovalent interactions including hydrogen HDAC inhibitor mechanism bonds, hydrophobic interaction, π-π interactions, and van der Waals forces have recently received considerable attention [8–13]. Up to now, LMOGs have become one of the hot areas in soft matter research due to their scientific values and many potential applications in wide fields, including nanomaterial templates, biosensors, controlled drug release, during medical implants, and so on [14–19]. The noncovalent nature of the 3D networks within the supramolecular gels promises accessibility for designing and constructing sensors, actuators, and other molecular devices [20–23]. In addition, in the recent several decades, luminol is considered as an efficient system in chemiluminescence and electrochemiluminescence (ECL) measurements for the detection of hydrogen peroxide [24–27]. In the previous work, we reported the design and synthesis of functional luminol derivatives with different substituted groups and investigated the interfacial assembly of these compounds with different methods [28, 29]. Therein, their potential for ECL measurement

has been demonstrated first. Meanwhile, their interfacial behavior and the morphologies of pure or mixed monolayers used to develop the biomimetic membrane were investigated [30]. The introduction of different substituted groups into those functional compounds can lead to new conjugated structures, and new properties are expected. Furthermore, in our reported work, the gelation properties of some cholesterol imide derivatives consisting of cholesteryl units and photoresponsive azobenzene substituent groups have been investigated [31]. Therein, we found that a subtle change in the headgroup of the azobenzene segment can produce a dramatic change in the gelation behavior of two compounds with/without methyl substituent groups described therein.

An aliquot of dilute solution was dropped and dried on a carbon-c

An aliquot of dilute solution was dropped and dried on a carbon-coated copper

grid. TEM images were then taken immediately. Figure 1 shows that the solution contains irregular particle clusters in addition to monodispersed particles. The sizes of the single particles were found to be close to 15 nm as specified by the supplier. The morphology of the monodispersed particles is spherical. Sonication of the nanofluid solution and addition of surfactant molecules is critical to break down the particle agglomerations and stabilize particle dispersion. The effective nanoparticle size was 260 nm measured with a particle size analyzer GSK1120212 chemical structure (Brookhaven Instruments Corporation, Holtsville, NY, USA). Adsorption of oleic acid surfactant molecules to the surface of TiO2 particles and dissociation of proton from carboxylic acid head groups result in net BGJ398 negative charges on the surface of particles and thus formation of electric double layer around them. Thick electric double layers cause the deviation of particle-particle interactions from hard-sphere interactions. The (Debye) length in nanometer of an electric double layer of 1:1 electrolyte in water at 25°C can be approximated by (where M is the molar concentration). For 0.01

vol.% concentration of oleic acid in water (which is 3.15 × 10-4 molar), the Debye length is estimated to be about 16.9 nm. Such a small increase in the effective Uroporphyrinogen III synthase diameter of particles allows for an assumption of hard-sphere interactions between particles in the solution which is an important assumption in using Krieger’s formula [32]. All other experimental measurements were carried out at 25°C. Figure 1 TEM nanographs

of 15 nm TiO 2 nanoparticles. Measurement of viscosity Viscosity of the solutions was measured using a controllable low shear rate concentric cylinders rheometer (Contraves, Low Shear 40, Zurich, Switzerland). The viscosity was measured at shear rates ranging from 0 to 50 s−1. This range corresponds to the shear rates that are common to capillary flow. Measurement of surface tension Surface tension of the solutions was measured by pendant droplet method using FTA200 system (First Ten Angstroms, Inc., Portsmouth, VA, USA). To form the pendant droplets, the solutions were pumped out of a syringe system at a very low rate, namely 1 μl/s, to minimize inertia effects. To minimize errors due to evaporation, surface tension was measured right after the pendant droplet reached its maximum volume, namely 10 μl for the dense solutions. Measurement of dynamic contact angle Dynamic contact angle of the solutions was measured using the FTA200 system. A droplet of solution was generated at a very low rate (1 μl/s) and detached from the syringe needle tip as soon as it touched the borosilicate glass slide.

Details of the synthesis procedure have been presented in a previ

Details of the synthesis procedure have been presented in a previous study [31]. A solution of AgNO3 (1 mM) in 250-mL ultrapure water was heated to 80°C. A volume of 10-mL aqueous solution of Na3C6H5O7 · 2H2O (0.34 mM) was then added to the AgNO3 solution. Heating was continued to 90°C for 30 min after adding the citrate solution. Venetoclax chemical structure The color of the solution changed from the colorless water to yellow after 15 min of heating and to gray after 25 min. The resulting sol is simply

silver nanoparticles coated with organic shell, dispersed in water at a concentration of 1 mM [32, 33]. Preparation of silver nanoparticle solution with different concentrations The different concentrations of the silver nanoparticle solution were

fabricated by increasing the concentration of the silver nanoparticle solution from 1 mM to 0.1 M by centrifugation. Centrifugation was conducted at 9,000 revolutions per minute (rpm) for 5 min in 10-mL centrifuge tubes. The water was extracted from the centrifuge tubes using a pipette, leaving aqueous-based Ag nanoparticle paste at the bottom. Shock the tube to make the nanoparticle paste back into suspension, then collect the https://www.selleckchem.com/products/ink128.html rest of the solution for the next centrifugation. Repeat this process until the required concentration solution was obtained. Preparation of silver nanoparticle films on silica substrates Silicon wafers with single side polished were cut into required size, depending on the demand. The prepared silicon wafers were cleaned by an ultrasonic cleaning machine using deionized water for 10 min. These silicon wafers were then laid in a container, and the container was placed on an inclined platform with the angle of inclination α = 10°. The schematic of this device is shown in Figure 1. The solution of silver nanoparticles prepared with different concentrations was poured into

the container. The evaporation was carried out inside an oven. This oven temperature was set to 50°C. After evaporation of the solvent, the self-assembled silver nanoparticle film was obtained. Figure 1 Schematic illustration of silver nanoparticles self-assembled Farnesyltransferase on silica substrate (a, b). Characterization techniques The absorption spectrum of the silver colloid was obtained using a UV-vis (UV-9000S, Shanghai Metash Instruments Co., Ltd., China) spectrophotometer. The morphology of the silver nanoparticles was examined by transmission electron microscopy (TEM; JEM-2010, JEOL Ltd., Akishima, Tokyo, Japan). The silver nanoparticle films were imaged using a scanning electron microscope (SEM; XL30 S-FEG, FEI Co., Hillsboro, OR, USA). The cross-sectional profiles of the silver nanoparticle films were measured using an atomic force microscope (AFM; Pico Scan TM 2500, Scientec, Les Ulis, France) and a Veeco surface profiler (Wyko NT1100, Veeco Instruments Inc., Plainview, NY, USA).

Kresse G, Furthmüller J: Efficient iterative schemes for ab initi

Kresse G, Furthmüller J: Efficient iterative schemes for ab initio total-energy calculations using a plane-wave basis set. Phys Rev B 1996,54(16):11169–11186.CrossRef 18. Blöchl PE: Projector augmented-wave method. Phys Rev B 1994,50(24):17953–17979.CrossRef 19. Kresse G, Joubert D: From ultrasoft pseudopotentials to the projector augmented-wave method. Phys Rev B 1999,59(3):1758–1775.CrossRef 20. Perdew JP, Burke K, Ernzerhof M: Generalized gradient approximation made simple. Phys Rev Lett 1996,77(18):3865–3868.CrossRef 21. Monkhorst HJ, Pack JD: Special points for Brillouin-zone integrations. Phys Rev B 1976,13(12):5188–5192.CrossRef 22. Timon V, Brand S, Clark SJ, gibson

MC, Abram RA: First-principles calculations of 2 × 2 reconstructions of GaN(0001) surfaces involving N, Al, Ga, In, and As atoms. Phys Rev B 2005,72(3):035327.CrossRef 23. Sadigh B, Lenosky TJ, mTOR inhibitor Caturla MJ, Quong AA, Benedict LX, de la Rubia TZ, Giles MM, Foad M, Selleckchem Panobinostat Spataru CD, Louie SG: Large enhancement of boron solubility in silicon due to biaxial stress. Appl Phys Lett 2002,80(25):4738–4740.CrossRef 24. Zhu J, Liu F, Stringfellow GB, Wei SH: Strain-enhanced doping in semiconductors: effects of dopant size and charge state. Phys Rev Lett 2010,105(19):195503.CrossRef 25. Zoroddu A, Bernardini F, Ruggerone P: First-principles prediction of structure, energetics,

formation enthalpy, elastic constants, polarization, and piezoelectric constants of AlN, GaN, and InN: comparison of local and gradient-corrected density-functional theory. Phys Rev B 2001,64(4):045208.CrossRef 26. Bungaro C, Rapcewicz

K, Bernholc J: Surface sensitivity of impurity incorporation: Mg at GaN (0001) surfaces. Phys Rev B 1999,59(15):9771–9774.CrossRef 27. PAK5 Hansen M, Chen LF, Lim SH, DenBaars SP, Speck JS: Mg-rich precipitates in the p -type doping of InGaN-based laser diodes. Appl Phys Lett 2002,80(14):2469–2471.CrossRef 28. Vennéguès P, Leroux M, Dalmasso S, Benaiisa M, De Mierry P, Lorenzini P, Damilano B, Beaumont B, Massies J, Gibart P: Atomic structure of pyramidal defects in Mg-doped GaN. Phys Rev B 2003,68(23):235214.CrossRef 29. Nakamura S, Iwasa N, Senoh M, Mukai T: Hole compensation mechanism of p-type GaN films. Japanese Journal of Applied Physics Part 1-Regular Papers Short Notes & Review Papers 1992,31(5A):1258–1266.CrossRef 30. Clerjaud B, Côte D, Lebkiri A, Naud C: Infrared spectroscopy of Mg-H local vibrational mode in GaN with polarized light. Phys Rev B 2000,61(12):8238–8241.CrossRef 31. Limpijumnong S, Northrup JE, Van de Walle CG: Entropy-driven stabilization of a novel configuration for acceptor-hydrogen complexes in GaN. Phys Rev Lett 2001,87(20):205505.CrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions TCZ carried out the experiments and drafted the manuscript. WHY, WJ and HYC helped in the preparation and characterization of the samples. JCL and SPL took part in the data analysis.